Skip to main content

Table 5 Risk factors of in-hospital mortality by univariate logistic regression analysis

From: Predictive ability of EuroSCORE II integrating cardiactroponin T in patients undergoing OPCABG

Variables

Total cohort (n = 1887)

cTnT group (n = 971)

hs-cTnT group (n = 916)

OR

95%CI

P

OR

95%CI

P

OR

95%CI

P

Age (y)

1.052

1.012–1.094

0.011

1.055

0.997–1.116

0.064

1.049

0.994–1.108

0.080

Female (n, %)

1.513

0.793–2.889

0.209

1.252

0.480–3.265

0.646

1.794

0.742–4.333

0.194

Weight (kg)

0.985

0.957–1.014

0.310

0.982

0.942–1.024

0.395

0.988

0.949–1.029

0.563

Height (cm)

0.984

0.945–1.024

0.422

0.965

0.911–1.022

0.223

1.001

0.946–1.060

0.961

NYHA classification (n, %)

2.425

1.562–3.766

0.000

2.552

1.329–4.901

0.005

2.321

1.286–4.191

0.005

Types of CAD (n, %)

1.231

0.776–1.951

0.377

2.256

1.129–4.509

0.021

0.720

0.363–1.427

0.347

Hypertention (n, %)

0.859

0.455–1.620

0.638

2.097

0.612–7.179

0.238

0.499

0.213–1.169

0.109

Diabetes (n, %)

1.450

0.781–2.694

0.239

1.512

0.630–3.626

0.354

1.409

0.584–3.398

0.446

Cerebrovascular disease (n, %)

0.210

0.050–0.871

0.032

0.292

0.067–1.261

0.099

0.000

0.000–0.000

0.997

Cr (μmol/l)

1.004

1.001–1.007

0.013

1.005

1.000–1.010

0.069

1.003

1.000–1.007

0.076

Ccr (ml/min/1.73 m2)

0.975

0.962–0.988

0.000

0.971

0.951–0.991

0.005

0.978

0.961–0.995

0.010

LVEF (%)

0.934

0.908–0.961

0.000

0.926

0.083–0.970

0.001

0.938

0.904–0.974

0.001

Number of diseased vessels (n)

1.071

0.539–2.126

0.845

2.542

0.426–15.184

0.306

0.757

0.362–1.585

0.461

Peripheral vascular disease (n, %)

4.296

1.470–12.556

0.008

3.466

0.770–15.608

0.105

5.86

1.256–27.349

0.024

Emergency operation (n, %)

6.096

2.602–14.284

0.000

11.143

2.943–42.187

0.000

4.398

1.427–13.559

0.010

Combined valvulardisease (n, %)

0.669

0.237–1.890

0.448

0.629

0.083–4.753

0.653

0.649

0.190–2.217

0.490

COPD (n, %)

0.805

0.109–5.956

0.831

0.000

0.000–0.000

0.998

1.283

0.167–9.834

0.811

Atrial flutter and fibrillation (n, %)

0.652

0.088–4.808

0.674

1.389

0.181–10.666

0.752

0.000

0.000–0.000

0.998

Pulmonary hypertension (n, %)

0.978

0.345–2.769

0.967

0.000

0.000–0.000

0.998

1.068

0.356–3.199

0.907

Previous PCI (n, %)

1.601

0.562–4.561

0.378

1.533

0.199–11.804

0.681

1.585

0.459–5.470

0.466

BMI (kg/m2)

0.960

0.870–1.060

0.424

0.988

0.860–1.135

0.864

0.934

0.810–1.077

0.348

Renal failure (n, %)

9.978

3.614–27.551

0.000

11.006

2.226–54.407

0.003

9.253

2.471–34.646

0.001

Euroscore II (%)

1.574

1.342–1.846

0.000

1.815

1.414–2.330

0.000

1.437

1.166–1.770

0.001

Myocardial injury classification (n, %)

2.049

1.542–2.722

0.000

3.564

2.105–6.035

0.000

1.963

1.322–2.915

0.001

  1. hs-cTnT, high sitivity cardiac troponin T; cTnT, cardiac troponin T; NYHA, New York Heart Association; BSA, body surface area; Cr, creatinine; Ccr, creatinine clearance rate; LVEF, left ventricular ejection fraction; COPD, chronic obstructive pulmonary disease; PCI, percutaneous coronary intervention; BMI, body mass index; EuroSCORE, European system for cardiac operative risk evaluation